<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Rupture of an <z:hpo ids='HP_0004944'>intracranial aneurysm</z:hpo> (<z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo>) is a potentially devastating condition frequently complicated by delayed <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> from sustained contraction of intracranial arteries (<z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>There is mounting evidence linking the formation of <z:hpo ids='HP_0004944'>intracranial aneurysms</z:hpo> and the pathogenesis of post-<z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> vasospasm to aberrant bioavailability and action of the <z:chebi fb="1" ids="35620">vasodilator</z:chebi> molecule nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> generated by isoforms of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase </plain></SENT>
<SENT sid="2" pm="."><plain>In humans, the gene encoding the endothelial isoform of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (eNOS) is known to be polymorphic, with certain polymorphisms associated with increased <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> susceptibility </plain></SENT>
<SENT sid="3" pm="."><plain>In this prospective clinical study involving 141 participants, we used gene microarray technology to demonstrate that the eNOS gene intron-4 27-base pair variable number tandem repeat polymorphism (eNOS 27 VNTR) predicts susceptibility to <z:hpo ids='HP_0004944'>intracranial aneurysm</z:hpo> rupture, while the eNOS gene promoter T-786C single nucleotide polymorphism (eNOS T-786C SNP) predicts susceptibility to post-<z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> vasospasm </plain></SENT>
<SENT sid="4" pm="."><plain>We believe that genetic information such as this, which can be obtained expeditiously at the time of diagnosis, may be used as a helpful adjunct to other clinical information aimed at predicting and favorably modifying the clinical course of persons with <z:hpo ids='HP_0004944'>intracranial aneurysms</z:hpo> </plain></SENT>
</text></document>